Company: WHWK
Filing Date: 2025-01-21
Form Type: PREM14A
Source: 0001193125-25-009599
Chunk: 251

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-01-21
Form: PREM14A
Chunk 251
---
 2,070,784 shares, (ii) four percent (4%) of the 
 outstanding shares of common stock on the last day of the immediately preceding fiscal year or (iii) such number of shares determined by our board of directors no later than the last day of the immediately preceding fiscal year. On 
 January 1, 2025, the number of shares available under the 2021 Plan increased by 987,228 shares pursuant to this feature.                                                                                                               |

| (3) | Our board of directors adopted, and our stockholders approved, the 2021 ESPP. The 2021 ESPP provides that the                                                                                                                               
 number of shares available for issuance under the 2021 ESPP will be increased on the first day of each fiscal year beginning with the 2022 fiscal year, in an amount equal to the least of (i) 310,617 shares, (ii) one percent (1%) of the 
 outstanding shares of common stock on the last day of the immediately preceding fiscal year or (iii) an amount determined by the administrator no later than the last day of the immediately preceding fiscal year. On January 1, 2025, the 
 number of shares available under the 2021 ESPP increased by 246,807 shares pursuant to this feature.                                                                                                                                        |

| (4) | Excludes (i) 987,228 additional shares of common stock that may be issued pursuant to our 2021 Plan pursuant to                                                                                                        
 an automatic annual increase effective on January 1, 2025 and (ii) 246,807 additional shares of common stock that may be issued pursuant to our 2021 ESPP pursuant to an annual increase effective on January 1, 2025. |

| (5) | Reflects (i) an option to acquire 490,000 shares at an exercise price per share equal to $4.30 issued                                                                                                   
 under the 2023 Plan and (ii) warrants issued for the purchase of 29,167 shares of common stock at an exercise price of $7.29 per share. These warrants are compensatory in nature and are fully vested. |

- 174 -

CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS The following is a description of each transaction since January 1, 2023, and each currently proposed transaction, in which we were a party and in which:

| • |     | the amounts involved exceeded or will exceed the lesser of $120,000 or 1